Schwartz J B, Caputo G, Abbott J
Department of Medicine, University of California, San Francisco.
J Am Geriatr Soc. 1993 Sep;41(9):967-74. doi: 10.1111/j.1532-5415.1993.tb06763.x.
To determine the effects of nifedipine-GITS (GITS = gastrointestinal transport system) on angina and cardiovascular responses to stress-dobutamine infusion, we used ultrafast cine-computed tomography (CT) to assess regional wall motion, myocardial perfusion, and indices of ventricular filling and emptying.
Randomized, double-blind placebo-controlled efficacy study after an open-label dose titration phase.
University of California, San Francisco.
Elderly patients (> 60 years; n = 9:8 male, 1 female) with coronary artery disease by history and diagnostic treadmill or coronary angiography.
After a 3-week open-label dose-titration phase, eight subjects were randomized to receive either placebo or nifedipine-GITS at the highest tolerated dose for 2 weeks, followed by a crossover to the alternate therapy for 2 weeks. One declined because of singulus in the open-label period.
Symptomatic angina relief (frequency and nitroglycerin consumption), dobutamine stress responses (time to ischemia during dobutamine infusions, cardiac output, cardiac ejection fraction, ventricular segmental wall motion, and perfusion as measured by ultrafast cine-CT), and reported adverse effects.
When compared with placebo, nifedipine-GITS administration was associated with less frequent angina and nitroglycerin consumption (NS) and significantly decreased systolic blood pressure. Nifedipine-GITS administration also increased resting supine heart rates. Dobutamine infusions increased heart rate, cardiac output, cardiac ejection fraction, and stroke volume and induced angina symptoms. Neither double product at angina nor systolic indices of cardiac function in response to dobutamine differed between nifedipine-GITS and placebo, although heart rate responses were greater during nifedipine. A trend toward increased peak filling rates was seen during dobutamine stress in the nifedipine-administration period. In most subjects (6/8), perfusion and regional wall motion abnormalities were not visualized on regional wall motion abnormalities were not visualized on either rest or stress cine-CT studies. Edema without congestive heart failure occurred frequently during nifedipine-GITS administration.
These data suggest that (1) dobutamine stress can be used to induce cardiac ischemia in elderly patients with coronary artery disease, (2) nifedipine-GITS provides symptomatic angina relief in elderly patients, (3) peripheral edema is frequent in elderly patients on nifedipine-GITS, and (4) ultrafast computed cine-tomography testing can be used to assess ventricular performance, but current methodology may not detect perfusion or wall motion abnormalities during angina.
为了确定硝苯地平胃肠道转运系统(GITS)对心绞痛以及应激-多巴酚丁胺输注时心血管反应的影响,我们使用超速电影计算机断层扫描(CT)来评估局部室壁运动、心肌灌注以及心室充盈和排空指标。
在开放标签剂量滴定阶段之后进行的随机、双盲、安慰剂对照疗效研究。
加利福尼亚大学旧金山分校。
有冠心病病史且经诊断性平板运动试验或冠状动脉造影确诊的老年患者(>60岁;n = 9,8名男性,1名女性)。
在为期3周的开放标签剂量滴定阶段之后,8名受试者被随机分配接受安慰剂或最高耐受剂量的硝苯地平GITS治疗2周,随后交叉接受替代治疗2周。1名受试者因在开放标签期出现异常而退出。
症状性心绞痛缓解情况(发作频率和硝酸甘油消耗量)、多巴酚丁胺应激反应(多巴酚丁胺输注期间出现缺血的时间、心输出量、心脏射血分数、心室节段性室壁运动以及通过超速电影CT测量的灌注)以及报告的不良反应。
与安慰剂相比,服用硝苯地平GITS时心绞痛发作频率和硝酸甘油消耗量较少(无统计学差异),收缩压显著降低。服用硝苯地平GITS还使静息仰卧心率增加。多巴酚丁胺输注使心率、心输出量、心脏射血分数和每搏量增加,并诱发心绞痛症状。硝苯地平GITS组和安慰剂组在心绞痛发作时的双乘积以及对多巴酚丁胺反应时的心脏功能收缩指标均无差异,尽管硝苯地平治疗期间心率反应更大。在硝苯地平给药期的多巴酚丁胺应激过程中,观察到峰值充盈率有增加趋势。在大多数受试者(6/8)中,无论是静息还是应激电影CT研究均未发现灌注和局部室壁运动异常。在服用硝苯地平GITS期间,经常出现无充血性心力衰竭的水肿。
这些数据表明,(1)多巴酚丁胺应激可用于诱发老年冠心病患者的心肌缺血,(2)硝苯地平GITS可缓解老年患者的症状性心绞痛,(3)老年患者服用硝苯地平GITS时外周水肿常见,(4)超速计算机电影断层扫描检测可用于评估心室功能,但目前的方法可能无法检测心绞痛期间的灌注或室壁运动异常。